Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_assertion description "[Erlotinib treatment at clinically relevant concentrations induced autophagy (increased LC3II expression, Atg-5/Atg12 conjugation, formation of AVO and p62 degradation) in sensitive NSCLC cell lines, via p53 nuclear translocation, AMPK activation and mTOR suppression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_assertion evidence source_evidence_literature NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_assertion SIO_000772 23769318 NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_assertion wasDerivedFrom befree-20150227 NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_assertion wasGeneratedBy ECO_0000203 NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.
- befree-20150227 importedOn "2015-02-27" NP876633.RAdLwFr72BKr0IcQtVVVmi0x98At9o3dfqq0z6-lXyark130_provenance.